Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adj

Affiliation auteurs!!!! Error affiliation !!!!
TitreProspective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adj
Type de publicationJournal Article
Year of Publication2017
AuteursGrothey A., Sobrero A., Meyerhardt J.A, Yoshino T., Paul J., Taieb J., Souglakos I., Kerr R., Labianca R., Shields A.F, Bonnetain F., Yamanaka T., Boukovinas I., Shi Q., Meyers J.P, Niedzwiecki D., Torri V., Sargent D.J, Andre T., Iveson T.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534